RAC 3.31% $1.61 race oncology ltd

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-37

  1. 6,807 Posts.
    lightbulb Created with Sketch. 1745
    Interesting that Dr.T refers to Bisantrene as the “lead asset”. What else do we have?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.